O	0	11	Lactoferrin	Lactoferrin	NN	B-NP
O	12	20	enhances	enhance	VBZ	B-VP
O	21	24	Fas	Fas	NN	B-NP
O	25	35	expression	expression	NN	I-NP
O	36	39	and	and	CC	O
O	40	49	apoptosis	apoptosis	NN	B-NP
O	50	52	in	in	IN	B-PP
O	53	56	the	the	DT	B-NP
B-Multi-tissue_structure	57	62	colon	colon	NN	I-NP
I-Multi-tissue_structure	63	69	mucosa	mucosa	NN	I-NP
O	70	72	of	of	IN	B-PP
O	73	85	azoxymethane	azoxymethane	NN	B-NP
O	85	86	-	-	HYPH	B-NP
O	86	93	treated	treat	VBN	I-NP
O	94	98	rats	rat	NNS	I-NP
O	98	99	.	.	.	O

O	101	107	Bovine	Bovine	JJ	B-NP
O	108	119	lactoferrin	lactoferrin	NN	I-NP
O	119	120	,	,	,	O
O	121	122	a	a	DT	B-NP
O	123	138	multifunctional	multifunctional	JJ	I-NP
O	139	151	glycoprotein	glycoprotein	NN	I-NP
O	151	152	,	,	,	O
O	153	156	has	have	VBZ	B-VP
O	157	161	been	be	VBN	I-VP
O	162	167	shown	show	VBN	I-VP
O	168	170	to	to	TO	I-VP
O	171	179	strongly	strongly	RB	I-VP
O	180	187	inhibit	inhibit	VB	I-VP
O	188	199	development	development	NN	B-NP
O	200	202	of	of	IN	B-PP
O	203	215	azoxymethane	azoxymethane	NN	B-NP
O	216	217	(	(	(	O
O	217	220	AOM	AOM	NN	B-NP
O	220	221	)	)	)	O
O	221	222	-	-	HYPH	B-NP
O	222	229	induced	induce	VBN	I-NP
O	230	233	rat	rat	NN	I-NP
B-Cancer	234	239	colon	colon	NN	I-NP
I-Cancer	240	246	tumors	tumor	NNS	I-NP
O	246	247	.	.	.	O

O	248	254	Little	Little	RB	B-ADVP
O	254	255	,	,	,	O
O	256	263	however	however	RB	B-ADVP
O	263	264	,	,	,	O
O	265	267	is	be	VBZ	B-VP
O	268	273	known	know	VBN	I-VP
O	274	279	about	about	IN	B-PP
O	280	283	the	the	DT	B-NP
O	284	294	inhibitory	inhibitory	JJ	I-NP
O	295	305	mechanisms	mechanism	NNS	I-NP
O	305	306	.	.	.	O

O	307	309	We	We	PRP	B-NP
O	310	314	have	have	VBP	B-VP
O	315	327	demonstrated	demonstrate	VBN	I-VP
O	328	336	recently	recently	RB	B-ADVP
O	337	341	that	that	IN	B-SBAR
O	342	353	lactoferrin	lactoferrin	NN	B-NP
O	354	362	enhances	enhance	VBZ	B-VP
O	363	366	the	the	DT	B-NP
O	367	377	expression	expression	NN	I-NP
O	378	380	of	of	IN	B-PP
O	381	382	a	a	DT	B-NP
O	383	389	member	member	NN	I-NP
O	390	392	of	of	IN	B-PP
O	393	396	the	the	DT	B-NP
O	397	402	tumor	tumor	NN	I-NP
O	403	411	necrosis	necrosis	NN	I-NP
O	412	418	factor	factor	NN	I-NP
O	419	427	receptor	receptor	NN	I-NP
O	428	434	family	family	NN	I-NP
O	434	435	,	,	,	O
O	436	439	Fas	Fas	NN	B-NP
O	439	440	,	,	,	O
O	441	443	in	in	IN	B-PP
O	444	447	the	the	DT	B-NP
B-Multi-tissue_structure	448	453	colon	colon	NN	I-NP
I-Multi-tissue_structure	454	460	mucosa	mucosa	NN	I-NP
O	461	467	during	during	IN	B-PP
O	468	472	both	both	CC	O
O	473	478	early	early	JJ	B-NP
O	479	482	and	and	CC	I-NP
O	483	487	late	late	JJ	I-NP
O	488	494	stages	stage	NNS	I-NP
O	495	497	of	of	IN	B-PP
O	498	512	carcinogenesis	carcinogenesis	NN	B-NP
O	512	513	.	.	.	O

O	514	518	Thus	Thus	RB	B-ADVP
O	518	519	,	,	,	O
O	520	523	Fas	Fas	NN	B-NP
O	524	529	could	could	MD	B-VP
O	530	532	be	be	VB	I-VP
O	533	541	involved	involve	VBN	I-VP
O	542	544	in	in	IN	B-PP
O	545	551	bovine	bovine	JJ	B-NP
O	552	563	lactoferrin	lactoferrin	NN	I-NP
O	563	564	-	-	HYPH	B-VP
O	564	572	mediated	mediate	VBN	B-NP
O	573	583	inhibition	inhibition	NN	I-NP
O	584	586	of	of	IN	B-PP
B-Cancer	587	592	tumor	tumor	NN	B-NP
O	593	604	development	development	NN	I-NP
O	604	605	.	.	.	O

O	606	608	To	To	TO	B-VP
O	609	620	investigate	investigate	VB	I-VP
O	621	625	this	this	DT	B-NP
O	626	637	possibility	possibility	NN	I-NP
O	637	638	,	,	,	O
O	639	641	we	we	PRP	B-NP
O	642	649	studied	study	VBD	B-VP
O	650	653	the	the	DT	B-NP
O	654	663	influence	influence	NN	I-NP
O	664	666	of	of	IN	B-PP
O	667	673	bovine	bovine	JJ	B-NP
O	674	685	lactoferrin	lactoferrin	NN	I-NP
O	686	688	on	on	IN	B-PP
O	689	692	Fas	Fas	NN	B-NP
O	692	693	-	-	HYPH	O
O	693	701	mediated	mediate	VBN	B-NP
O	702	711	apoptosis	apoptosis	NN	I-NP
O	712	716	with	with	IN	B-PP
O	717	723	regard	regard	NN	B-NP
O	724	726	to	to	TO	B-PP
O	727	737	expression	expression	NN	B-NP
O	738	740	of	of	IN	B-PP
O	741	744	Fas	Fas	NN	B-NP
O	744	745	,	,	,	O
O	746	756	activation	activation	NN	B-NP
O	757	759	of	of	IN	B-PP
O	760	767	caspase	caspase	NN	B-NP
O	767	768	-	-	HYPH	B-NP
O	768	769	8	8	CD	I-NP
O	770	773	and	and	CC	I-NP
O	774	781	caspase	caspase	NN	I-NP
O	781	782	-	-	HYPH	B-NP
O	782	783	3	3	CD	I-NP
O	783	784	,	,	,	O
O	785	788	and	and	CC	O
O	789	792	DNA	DNA	NN	B-NP
O	793	806	fragmentation	fragmentation	NN	I-NP
O	807	809	in	in	IN	B-PP
O	810	813	the	the	DT	B-NP
B-Multi-tissue_structure	814	819	colon	colon	NN	I-NP
I-Multi-tissue_structure	820	826	mucosa	mucosa	NN	I-NP
O	827	829	of	of	IN	B-PP
O	830	833	AOM	AOM	NN	B-NP
O	833	834	-	-	HYPH	B-NP
O	834	841	treated	treat	VBN	I-NP
O	842	846	rats	rat	NNS	I-NP
O	846	847	.	.	.	O

O	848	855	Western	Western	NN	B-NP
O	856	860	blot	blot	NN	I-NP
O	861	869	analysis	analysis	NN	I-NP
O	870	882	demonstrated	demonstrate	VBD	B-VP
O	883	884	a	a	DT	B-NP
O	885	886	>	>	SYM	I-NP
O	886	887	2	2	CD	I-NP
O	887	888	.	.	SYM	I-NP
O	888	889	5	5	CD	I-NP
O	889	890	-	-	HYPH	I-NP
O	890	894	fold	fold	JJ	I-NP
O	895	903	increase	increase	NN	I-NP
O	904	906	in	in	IN	B-PP
O	907	910	Fas	Fas	NN	B-NP
O	911	918	protein	protein	NN	I-NP
O	919	929	expression	expression	NN	I-NP
O	929	930	,	,	,	O
O	931	933	as	as	RB	B-CONJP
O	934	938	well	well	RB	I-CONJP
O	939	941	as	as	IN	I-CONJP
O	942	951	elevation	elevation	NN	B-NP
O	952	954	of	of	IN	B-PP
O	955	958	the	the	DT	B-NP
O	959	965	active	active	JJ	I-NP
O	966	971	forms	form	NNS	I-NP
O	972	974	of	of	IN	B-PP
O	975	979	both	both	CC	O
O	980	987	caspase	caspase	NN	B-NP
O	987	988	-	-	HYPH	B-NP
O	988	989	8	8	CD	I-NP
O	990	993	and	and	CC	I-NP
O	994	1001	caspase	caspase	NN	I-NP
O	1001	1002	-	-	HYPH	B-NP
O	1002	1003	3	3	CD	I-NP
O	1003	1004	.	.	.	O

O	1005	1024	Immunohistochemical	Immunohistochemical	JJ	B-NP
O	1025	1033	analysis	analysis	NN	I-NP
O	1034	1042	revealed	reveal	VBD	B-VP
B-Cell	1043	1046	Fas	Fas	NN	B-NP
I-Cell	1046	1047	-	-	HYPH	B-NP
I-Cell	1047	1055	positive	positive	JJ	I-NP
I-Cell	1056	1061	cells	cell	NNS	I-NP
O	1062	1065	and	and	CC	O
O	1066	1075	apoptotic	apoptotic	JJ	B-NP
B-Cell	1076	1081	cells	cell	NNS	I-NP
O	1082	1096	preferentially	preferentially	RB	B-ADVP
O	1097	1103	within	within	IN	B-PP
O	1104	1107	the	the	DT	B-NP
O	1108	1116	proximal	proximal	JJ	I-NP
B-Organ	1117	1122	colon	colon	NN	I-NP
O	1123	1129	region	region	NN	I-NP
O	1129	1130	,	,	,	O
O	1131	1138	clearly	clearly	RB	B-ADVP
O	1139	1141	at	at	IN	B-PP
O	1142	1145	the	the	DT	B-NP
O	1146	1150	site	site	NN	I-NP
O	1151	1153	of	of	IN	B-PP
O	1154	1160	bovine	bovine	JJ	B-NP
O	1161	1172	lactoferrin	lactoferrin	NN	I-NP
O	1172	1173	-	-	HYPH	B-VP
O	1173	1181	mediated	mediate	VBN	B-NP
B-Cancer	1182	1187	tumor	tumor	NN	I-NP
O	1188	1198	inhibition	inhibition	NN	I-NP
O	1198	1199	.	.	.	O

O	1200	1205	These	These	DT	B-NP
O	1206	1213	results	result	NNS	I-NP
O	1214	1221	suggest	suggest	VBP	B-VP
O	1222	1226	that	that	IN	B-SBAR
O	1227	1236	apoptosis	apoptosis	NN	B-NP
O	1237	1243	caused	cause	VBN	B-VP
O	1244	1246	by	by	IN	B-PP
O	1247	1255	elevated	elevate	VBN	B-NP
O	1256	1266	expression	expression	NN	I-NP
O	1267	1269	of	of	IN	B-PP
O	1270	1273	Fas	Fas	NN	B-NP
O	1274	1276	is	be	VBZ	B-VP
O	1277	1285	involved	involve	VBN	I-VP
O	1286	1288	in	in	IN	B-PP
O	1289	1304	chemoprevention	chemoprevention	NN	B-NP
O	1305	1307	by	by	IN	B-PP
O	1308	1319	lactoferrin	lactoferrin	NN	B-NP
O	1320	1322	of	of	IN	B-PP
B-Organ	1323	1328	colon	colon	NN	B-NP
O	1329	1343	carcinogenesis	carcinogenesis	NN	I-NP
O	1343	1344	.	.	.	O

